Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Jacob

Showing results (151-160 of 183) with videos related to

Pageof 19
Sort By:
Frontiers in Immunology|December 16, 2020
Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians SurveyAnnick A J M van de Ven, Tiago M Alfaro, Alexandra Robinson, et al.
The European Respiratory Journal|June 15, 2019
Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysisJoseph Jacob, Brian J Bartholmai, Coline H M van Moorsel, et al.
The European Respiratory Journal|June 25, 2026
Clinical Practice Guideline for the diagnosis of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency Disorders (CVID) - an ERS Clinical Research CollaborationHeba M Bintalib, Annick A J M van de Ven, Maria X Rojas-Reyes, et al.
The European Respiratory Journal|November 30, 2018
Predicting outcomes in rheumatoid arthritis related interstitial lung diseaseJoseph Jacob, Nikhil Hirani, Coline H M van Moorsel, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Clinical utility of lung biopsy in fibrotic interstitial lung diseaseElad Mor, Sara Piciucchi, Claudia Ravaglia, et al.
American Journal of Respiratory and Critical Care Medicine|April 24, 2018
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic AnalysisJoseph Jacob, Brian J Bartholmai, Srinivasan Rajagopalan, et al.
American Journal of Respiratory and Critical Care Medicine|July 10, 2018
Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative AnalysisXiaoping Wu, Grace H Kim, Margaret L Salisbury, et al.
ERJ Open Research|August 26, 2021
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysemaAn Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, et al.
Urologic Oncology|July 3, 2021
Comprehensive genomic profiling of histologic subtypes of urethral carcinomasJoseph Jacob, Andrea Necchi, Petros Grivas, et al.
Cytotherapy|April 3, 2026
A first-in-human phase I clinical trial investigating the safety and efficacy of repeat dosing MSCTRAIL cell therapy in addition to chemotherapy and immunotherapy in patients with advanced lung cancerRebecca N Graham, Alice Davies, Monica L Mullin, et al.
Pageof 19

Showing results (151-160 of 183) with videos related to

Sort By:
Pageof 19
Frontiers in Immunology|December 16, 2020
Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians SurveyAnnick A J M van de Ven, Tiago M Alfaro, Alexandra Robinson, et al.
The European Respiratory Journal|June 15, 2019
Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysisJoseph Jacob, Brian J Bartholmai, Coline H M van Moorsel, et al.
The European Respiratory Journal|June 25, 2026
Clinical Practice Guideline for the diagnosis of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency Disorders (CVID) - an ERS Clinical Research CollaborationHeba M Bintalib, Annick A J M van de Ven, Maria X Rojas-Reyes, et al.
The European Respiratory Journal|November 30, 2018
Predicting outcomes in rheumatoid arthritis related interstitial lung diseaseJoseph Jacob, Nikhil Hirani, Coline H M van Moorsel, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Clinical utility of lung biopsy in fibrotic interstitial lung diseaseElad Mor, Sara Piciucchi, Claudia Ravaglia, et al.
American Journal of Respiratory and Critical Care Medicine|April 24, 2018
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic AnalysisJoseph Jacob, Brian J Bartholmai, Srinivasan Rajagopalan, et al.
American Journal of Respiratory and Critical Care Medicine|July 10, 2018
Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative AnalysisXiaoping Wu, Grace H Kim, Margaret L Salisbury, et al.
ERJ Open Research|August 26, 2021
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysemaAn Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, et al.
Urologic Oncology|July 3, 2021
Comprehensive genomic profiling of histologic subtypes of urethral carcinomasJoseph Jacob, Andrea Necchi, Petros Grivas, et al.
Cytotherapy|April 3, 2026
A first-in-human phase I clinical trial investigating the safety and efficacy of repeat dosing MSCTRAIL cell therapy in addition to chemotherapy and immunotherapy in patients with advanced lung cancerRebecca N Graham, Alice Davies, Monica L Mullin, et al.
Pageof 19